A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
-
* Corresponding author: Jose A Lopez-Guerrero jalopez@fivo.org
- Equal contributors
BMC Cancer 2010, 10:36 doi:10.1186/1471-2407-10-36
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 03 Sep 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 16 Sep 2009 |
| Reviewer's Report | Laure Dossus | 28 Oct 2009 | |
| Reviewer's Report | Reiner Strick | 12 Nov 2009 | |
| Reviewer's Report | Shiuan Chen | 18 Nov 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 01 Dec 2009 |
| Reviewer's Report | Laure Dossus | 09 Dec 2009 | |
| Editorial acceptance | 31 Jan 2010 | ||
| Published | 09 Feb 2010 |